Complete financial analysis of Yidu Tech Inc. (2158.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Yidu Tech Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Bank of Nanjing Co., Ltd. (601009.SS) Income Statement Analysis – Financial Results
- Telesis Bio, Inc. (TBIO) Income Statement Analysis – Financial Results
- Neste Oyj (NEF.DE) Income Statement Analysis – Financial Results
- Brimstone Investment Corporation Limited (BRN.JO) Income Statement Analysis – Financial Results
- Renesas Electronics Corporation (6723.T) Income Statement Analysis – Financial Results
Yidu Tech Inc. (2158.HK)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.yidutechgroup.com
About Yidu Tech Inc.
Yidu Tech Inc. provides healthcare solutions built on big data and artificial intelligence technologies in Mainland China, Brunei, and internationally. The company operates through Big Data Platform and Solutions, Life Sciences Solutions, Health Management Platform and Solutions, and Others segments. The Big Data Platform and Solutions segment offers data intelligence platforms and data analytics-driven solutions to hospitals, other healthcare institutions, regulators, and policy makers. This segment also provides applications and solutions to hospitals focusing on research, clinical diagnosis and treatment, and hospital operations management; DPAP/Eywa platforms for hospitals and medical institutions; and intelligent research and clinical and management solutions to medical customers. The Life Sciences Solutions segment offers analytics-driven clinical development, real-world evidence (RWE)-based research, and digital commercialization solutions to pharmaceutical, biotech, medical device, and other companies. The Health Management Platform and Solutions segment provides health management platform application and solution services; and insurance technology and solutions to insurance companies, agencies, and related regulators and policy makers. This segment also engages in the distribution of insurance companies products; and sale of pharmaceutical products and related hardware and other services. The Others segment is involved in the sale of computer hardware. The company also engages in the sale of medical devices; insurance brokerage activities; and medical and computer technology development activities. Yidu Tech Inc. was incorporated in 2014 and is headquartered in Beijing, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 807.08M | 804.70M | 1.24B | 867.04M | 558.08M | 102.01M | 22.73M |
| Cost of Revenue | 467.63M | 530.20M | 840.31M | 539.70M | 411.55M | 96.30M | 23.66M |
| Gross Profit | 339.45M | 274.50M | 396.90M | 327.34M | 146.54M | 5.71M | -934.00K |
| Gross Profit Ratio | 42.06% | 34.11% | 32.08% | 37.75% | 26.26% | 5.60% | -4.11% |
| Research & Development | 232.93M | 342.52M | 368.66M | 221.86M | 263.68M | 257.62M | 153.61M |
| General & Administrative | 171.30M | 231.99M | 337.03M | 309.93M | 47.51M | 29.06M | 12.99M |
| Selling & Marketing | 208.91M | 271.64M | 413.93M | 239.01M | 170.70M | 101.33M | 49.21M |
| SG&A | 380.21M | 564.63M | 798.28M | 548.95M | 218.21M | 130.39M | 62.20M |
| Other Expenses | -53.77M | 391.00K | -18.88M | -3.27B | -924.83M | -498.62M | -712.35M |
| Operating Expenses | 559.36M | 979.59M | 1.17B | 743.28M | 727.37M | 437.43M | 243.61M |
| Cost & Expenses | 1.03B | 1.51B | 2.01B | 1.28B | 1.14B | 533.73M | 267.28M |
| Interest Income | 143.29M | 76.15M | 1.30M | 2.37M | 6.07M | 310.00K | 139.00K |
| Interest Expense | 3.31M | 2.61M | 4.21M | 3.29M | 4.20M | 3.10M | 2.47M |
| Depreciation & Amortization | 47.11M | 46.35M | 46.94M | 36.42M | 36.76M | 33.41M | 21.55M |
| EBITDA | -170.77M | -579.98M | -715.70M | -3.65B | -1.47B | -896.61M | -954.33M |
| EBITDA Ratio | -21.16% | -73.55% | -59.53% | -423.10% | -261.67% | -872.66% | -4,147.58% |
| Operating Income | -219.92M | -617.60M | -759.83M | -453.29M | -597.43M | -432.21M | -252.35M |
| Operating Income Ratio | -27.25% | -76.75% | -61.41% | -52.28% | -107.05% | -423.68% | -1,110.34% |
| Total Other Income/Expenses | -1.27M | 1.11M | 552.00K | -3.24B | -913.47M | -500.91M | -726.00M |
| Income Before Tax | -221.19M | -628.94M | -766.85M | -3.69B | -1.51B | -933.12M | -978.34M |
| Income Before Tax Ratio | -27.41% | -78.16% | -61.98% | -425.98% | -270.73% | -914.71% | -4,304.76% |
| Income Tax Expense | 49.00K | 3.42M | 486.00K | 1.42M | 533.00K | 569.00K | 26.00K |
| Net Income | -194.94M | -627.97M | -762.32M | -3.70B | -1.51B | -933.59M | -978.37M |
| Net Income Ratio | -24.15% | -78.04% | -61.62% | -426.77% | -270.55% | -915.17% | -4,304.87% |
| EPS | -0.19 | -0.63 | -0.80 | -7.24 | -3.74 | -1.04 | -1.08 |
| EPS Diluted | -0.19 | -0.63 | -0.80 | -7.24 | -3.74 | -1.04 | -1.08 |
| Weighted Avg Shares Out | 1.05B | 995.20M | 957.78M | 510.77M | 403.89M | 901.76M | 901.76M |
| Weighted Avg Shares Out (Dil) | 1.05B | 995.20M | 957.78M | 510.77M | 403.89M | 901.76M | 901.76M |
Source: https://incomestatements.info
Category: Stock Reports